| Income Statement |
| Total Revenue | 3.25M |
|
| Revenues (USD) | 3.25M |
| Cost of Revenue | 1.64M |
| Gross Profit | 1.61M |
| Operating Expenses | 4.75M |
| Research and Development Expense | 1.29M |
| Selling, General and Administrative Expense | 3.46M |
| Operating Income | -3.14M |
| Net Income | -3.17M |
| Net Income Common Stock | -3.17M |
| Net Income Common Stock (USD) | -3.17M |
| Consolidated Income | -3.17M |
| Earnings per Basic Share | -0.34 |
| Earnings per Basic Share (USD) | -0.34 |
| Earnings per Diluted Share | -0.34 |
| Earning Before Interest & Taxes (EBIT) | -3.17M |
| Earning Before Interest & Taxes (USD) | -3.17M |
| Weighted Average Shares | 9.39M |
| Weighted Average Shares Diluted | 9.39M |
| Balance Sheet |
| Cash and Equivalents | 5.71M |
| Cash and Equivalents (USD) | 5.71M |
| Trade and Non-Trade Receivables | 2.39M |
| Current Assets | 14.97M |
| Property, Plant & Equipment Net | 700.00K |
| Total Assets | 17.62M |
| Total Debt | 1.24M |
| Current Liabilities | 5.68M |
| Debt Non-Current | 1.24M |
| Total Liabilities | 7.16M |
| Accumulated Retained Earnings (Deficit) | -14.14M |
| Accumulated Other Comprehensive Income | 480.00K |
| Shareholders Equity | 10.46M |
| Shareholders Equity (USD) | 10.46M |
| Assets Non-Current | 2.65M |
| Total Debt (USD) | 1.24M |
| Deferred Revenue | 1.50M |
| Inventory | 6.15M |
| Liabilities Non-Current | 1.49M |
| Trade and Non-Trade Payables | 1.25M |
| Tax Liabilities | 254.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 115.00K |
| Net Cash Flow from Financing | -13.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.25M |
| Capital Expenditure | -8.00K |
| Issuance (Purchase) of Equity Shares | -13.00K |
| Net Cash Flow from Investing | -8.00K |
| Net Cash Flow from Operations | -2.23M |
| Effect of Exchange Rate Changes on Cash | 54.00K |
| Share Based Compensation | 77.00K |